(followed by Illumina, SOLiD, and now Helicos), there has been an explosion of genomes 48 sequenced under the moniker 'draft', however these can be very poor quality genomes 49 (due to inherent errors in the sequencing technologies, and the inability of assembly 50 programs to fully address these errors). Further, one can only infer that such draft 51 genomes may be of poor quality by navigating through the databases to find the 52 number and type of reads deposited in sequence trace repositories (and not all 53 genomes have this available), or to identify the number of contigs or genome fragments 54 deposited to the database. The difficulty in assessing the quality of such deposited 55 genomes has created some havoc for genome analysis pipelines and contributed to 56 many wasted hours of (mis)interpretation. 57
These same novel sequencing technologies have also brought an exponential 58 leap in raw sequencing capability, and at greatly reduced prices that have further 59 skewed the time-and cost-ratios of draft data generation versus the painstaking process 60 of improving and finishing a genome. The resulting effect is an ever-widening gap 61 between drafted and finished genomes that only promises to continue (Figure 1 
